Advertisement

Thermal Neutron Capture Therapy: The Japanese-Australian Clinical Trial for Malignant Melanoma

  • B. J. Allen
  • A. S. Coates
  • W. H. McCarthy
  • H. Mameghan
  • Y. Mishima
  • M. Ichihashi
Part of the Basic Life Sciences book series (BLSC, volume 50)

Abstract

Australians of Anglo-Celtic origin are constitutionally unsuited to living in a tropical environment. They suffer not only from weathered skin, solar keratoses, basal and squamous cell carcinomas, but also from an increasing incidence of malignant melanoma1. The northern state of Queensland has the highest incidence of melanoma in the world, at 35 cases per 100,000. New South Wales has half that rate, but because of the larger population and centralised nature of treatment, the Sydney Melanoma Unit has the largest case load in the world, with more than 700 new cases each year. Despite early diagnosis and curative surgery in the majority of these patients, there remain a number of patients with locally recurrent or metastatic melanoma which present a therapeutic challenge. Current therapy for these patients is almost always unsatisfactory.

Keywords

Isolate Limb Perfusion Amelanotic Melanoma Royal Prince Alfred Hospital Solar Keratose Sydney Melanoma Unit 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    W.H. McCarthy, Malignant Melanoma. Recent Advances in Surgery, Churchill and Livingston, Ch5: 87–100 (1982).Google Scholar
  2. 2.
    B.J. Allen, Australian-Japan Workshop on Neutron Capture Therapy for Malignant Melanoma. Cancer Forum, 10. 2: 64 (1986).Google Scholar
  3. 3.
    Y. Mishima, Second Japan-Australia Workshop on Neutron Capture Therapy for Malignant Melanoma, Kobe, Sept 1987. Papers submitted to Pigment Cell Research.Google Scholar
  4. 4.
    Y. Mishima, Selective thermal neutron capture therapy of cancer cells using their specific functional differentiation. Kyoto University Research Reactor Institute - Technical Report KURRI-TR 195: 1 (1980).Google Scholar
  5. 5.
    Y. Mishima, Selective thermal neutron capture treatment of malignant melanoma using its specific metabolic activity. KURRI-TR 260: 1 (1985).Google Scholar
  6. 6.
    H. Fukuda, T. Kobayashi, T. Matsuzawa, K. Kanda, M. Ichihashi, Y. Mishima, RBE of a thermal neutron beam and the 10B(m,a)7Li reaction on cultured B16 melanoma cells, Int. J. Radiat. Biol. 51: 167 (1987).CrossRefGoogle Scholar
  7. 7.
    M. Tsuji, M. Ichihashi, Y. Mishima, Selective affinity of 10B-paraboronophenylalanine to malignant melanoma, Japanese J. Derm. 93. 7: 773 (1983).Google Scholar
  8. 8.
    Y. Mishima, M. Ichihashi, M. Tsuji, M. Ueda, S. Hatta, T. Nakagawa, C. Tanaka, K. Taniyama, T. Suzuki, Prerequisites of first clinical trials for melanoma selective thermal neutron capture therapy. Neutron Capture Therapy. Proc. Sec. Int. Symp. Tokyo, October 1985, Nishimura 230 (1986).Google Scholar
  9. 9.
    A.B Miller, B. Hoogstraten, M. Staquet, A. Winkler, Cancer, 47:207 (1981).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • B. J. Allen
    • 1
  • A. S. Coates
    • 2
  • W. H. McCarthy
    • 2
  • H. Mameghan
    • 3
  • Y. Mishima
    • 4
  • M. Ichihashi
    • 4
  1. 1.Australian Nuclear Science & Technology OrganisationMenaiAustralia
  2. 2.The Sydney Melanoma UnitRoyal Prince Alfred HospitalCamperdownAustralia
  3. 3.Radiation OncologyPrince of Wales HospitalRandwickAustralia
  4. 4.The Institute for Neutron Capture TherapyKobe University HospitalChuo-ku KobeJapan

Personalised recommendations